FDA Approves AstraZeneca Tagrisso For Lung Cancer Treatment

November 13, 2015 4:11 PM

28 0

FDA Approves AstraZeneca Tagrisso For Lung Cancer Treatment

FDA announced the approval of AstraZenerca’s Tagrisso to treat non-small cell lung cancer

In a press release today, the US Food and Drug Administration (FDA) made an announcement that it has granted approval for an oral medication to treat patients who suffer from advanced non-small cell lung cancer (NSCLC). In this regard, AstraZeneca plc’s (NYSE:AZN) Tagrisso received FDA approval.

Also read: Senate Clears Bill to Ease FDA Drug and Device Approvals

Read more

To category page

Loading...